Invention Grant
- Patent Title: Compounds which modulate the CB2 receptor
- Patent Title (中): 调节CB2受体的化合物
-
Application No.: US13022866Application Date: 2011-02-08
-
Publication No.: US08829034B2Publication Date: 2014-09-09
- Inventor: Angela Berry , Pier Francesco Cirillo , Eugene Richard Hickey , Doris Riether , David Thomson , Renee M. Zindell , Nigel Blumire , Chandana Parke , Monika Ermann , James Edward Jenkins , Innocent Mushi , Christopher Francis Palmer , Malcolm Taylor
- Applicant: Angela Berry , Pier Francesco Cirillo , Eugene Richard Hickey , Doris Riether , David Thomson , Renee M. Zindell , Nigel Blumire , Chandana Parke , Monika Ermann , James Edward Jenkins , Innocent Mushi , Christopher Francis Palmer , Malcolm Taylor
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingerlheim International GmbH
- Current Assignee: Boehringer Ingerlheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Anthony P. Bottino
- Main IPC: C07D409/04
- IPC: C07D409/04 ; C07D309/02 ; A61K31/351 ; A61K31/42 ; C07D261/12 ; C07D217/22 ; C07D277/82 ; C07D309/04 ; C07D277/46 ; C07C317/44 ; C07D213/75 ; C07D417/12 ; C07D407/12 ; C07D405/12 ; C07D413/12 ; C07D215/38 ; C07D403/12 ; C07D231/40
Abstract:
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Public/Granted literature
- US20110130431A1 Compounds Which Modulate The CB2 Receptor Public/Granted day:2011-06-02
Information query
